Product Code: GVR-1-68038-922-7
Cartilage Repair Market Growth & Trends:
The global cartilage repair market size is expected to reach USD 8.04 billion by 2030, registering a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to the increasing prevalence of bone & joint disorders, such as Osteoarthritis (OA), rising geriatric population, and surge in the number of accidents & related injuries across the globe.
An increasing number of road accidents worldwide is causing bone and joint injuries, which is anticipated to fuel the demand for cartilage repair products over the forecast period. According to the WHO, in December 2023, every year, around 20 and 50 million more people suffer non-fatal injuries, resulting in a disability.
Around 30.0 million children and adolescents participate in youth sports in the U.S each year. This increase in sports activity increases incidents of injuries in athletes, which in turn propels the demand for cartilage repair products. According to research data by the American Orthopedic Society for Sports Medicine, over 3.5 million athletes receive medical treatment due to sports injuries each year.
Cartilage Repair Market Report Highlights:
- The cell-based modalities segment held the largest market share of over 60.5% in 2024 and is expected to grow at the fastest CAGR during the forecast period
- This growth can be attributed to the rising preference for autologous chondrocyte transplantation for surgically treating damaged articular cartilage.
- The intrinsic repair stimulus segment commanded highest market revenue share in 2024 due to the growing preference for techniques that stimulate the body's own repair mechanisms, such as microfracture and drilling procedures
- The knee cartilage repair segment is expected to grow at the highest CAGR during the forecast period due to rising demand for advanced and minimally invasive procedures that effectively treat knee cartilage damage
- The hyaline cartilage segment held a significant market revenue share in 2024 due to its high susceptibility to damage in case of cartilage-related injuries and an increase in sports injuries.
- North America dominated the global market in 2024, owing to the rising prevalence of bone & joint disorders, an increase in the number of accidents & injuries, and a growing geriatric population.
- According to an article in the National Library of Medicine, the prevalence of doctor-diagnosed arthritis in the U.S. is projected to increase to 49%, accounting for 78.4 million people (25.9% of the adult population) by 2040
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Treatment Modality
- 1.2.2. Treatment
- 1.2.3. Site
- 1.2.4. Application
- 1.2.5. Regional Scope
- 1.2.6. Estimates and Forecasts Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Treatment Modality
- 2.2.2. Treatment
- 2.2.3. Site
- 2.2.4. Application
- 2.2.5. Regional
- 2.3. Competitive Insights
Chapter 3. Cartilage Repair Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Cartilage Repair Market Analysis tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrant
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Cartilage Repair Market: Treatment Modality Estimates & Trend Analysis
- 4.1. Treatment Modality Segment Dashboard
- 4.2. Cartilage Repair Market: Treatment Modality Movement Analysis
- 4.3. Global Cartilage Repair Market Size & Trend Analysis, by Treatment Modality, 2018 to 2030 (USD Million)
- 4.4. Cell based Cartilage Repair
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.2. Chondrocyte Transplantation/ACI
- 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.3. Growth Factor Technology
- 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.4. Others
- 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5. Non-cell based Cartilage Repair
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.2. Tissue Scaffolds
- 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.3. Cell Free Composites
- 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5.4. Others
- 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Cartilage Repair Market: Treatment Estimates & Trend Analysis
- 5.1. Treatment Segment Dashboard
- 5.2. Cartilage Repair Market: Treatment Movement Analysis
- 5.3. Global Cartilage Repair Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
- 5.4. Palliative
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.4.2. Viscosupplementation
- 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.4.3. Debridement & Lavage
- 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.5. Intrinsic Repair Stimulus
Chapter 6. Cartilage Repair Market: Site Estimates & Trend Analysis
- 6.1. Site Segment Dashboard
- 6.2. Cartilage Repair Market: Site Movement Analysis
- 6.3. Global Cartilage Repair Market Size & Trend Analysis, by Site, 2018 to 2030 (USD Million)
- 6.4. Knee Cartilage Repair
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. Arthroscopic Chondroplasty
- 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.3. Autologous Chondrocyte
- 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.4. Osteochondral Grafts Transplantation
- 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.5. Microfracture
- 6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.6. Others
- 6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5. Others
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Cartilage Repair Market: Application Estimates & Trend Analysis
- 7.1. Application Segment Dashboard
- 7.2. Cartilage Repair Market: Application Movement Analysis
- 7.3. Global Cartilage Repair Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 7.4. Hyaline Cartilage
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5. Fibrocartilage
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Cartilage Repair Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market Share Analysis, 2024 & 2030
- 8.3. Continuous Bioprocessing Market By Region: Key Takeaways
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key Country Dynamics
- 8.4.1.2. Regulatory Framework/ Reimbursement Structure
- 8.4.1.3. Competitive Scenario
- 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.2. Canada
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Regulatory Framework/ Reimbursement Structure
- 8.4.2.3. Competitive Scenario
- 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.3. Mexico
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Regulatory Framework/ Reimbursement Structure
- 8.4.3.3. Competitive Scenario
- 8.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5. Europe
- 8.5.1. UK
- 8.5.1.1. Key Country Dynamics
- 8.5.1.2. Regulatory Framework/ Reimbursement Structure
- 8.5.1.3. Competitive Scenario
- 8.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.2. Germany
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Regulatory Framework/ Reimbursement Structure
- 8.5.2.3. Competitive Scenario
- 8.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.3. France
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Regulatory Framework/ Reimbursement Structure
- 8.5.3.3. Competitive Scenario
- 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.4. Italy
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Regulatory Framework/ Reimbursement Structure
- 8.5.4.3. Competitive Scenario
- 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.5. Spain
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Regulatory Framework/ Reimbursement Structure
- 8.5.5.3. Competitive Scenario
- 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.6. Denmark
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Regulatory Framework/ Reimbursement Structure
- 8.5.6.3. Competitive Scenario
- 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Regulatory Framework/ Reimbursement Structure
- 8.5.7.3. Competitive Scenario
- 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.8. Norway
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Regulatory Framework/ Reimbursement Structure
- 8.5.8.3. Competitive Scenario
- 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key Country Dynamics
- 8.6.1.2. Regulatory Framework/ Reimbursement Structure
- 8.6.1.3. Competitive Scenario
- 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.2. China
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Regulatory Framework/ Reimbursement Structure
- 8.6.2.3. Competitive Scenario
- 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.3. India
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Regulatory Framework/ Reimbursement Structure
- 8.6.3.3. Competitive Scenario
- 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.4. Australia
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Regulatory Framework/ Reimbursement Structure
- 8.6.4.3. Competitive Scenario
- 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Regulatory Framework/ Reimbursement Structure
- 8.6.5.3. Competitive Scenario
- 8.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.6. Thailand
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Regulatory Framework/ Reimbursement Structure
- 8.6.6.3. Competitive Scenario
- 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Brazil
- 8.7.1.1. Key Country Dynamics
- 8.7.1.2. Regulatory Framework/ Reimbursement Structure
- 8.7.1.3. Competitive Scenario
- 8.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7.2. Argentina
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Framework/ Reimbursement Structure
- 8.7.2.3. Competitive Scenario
- 8.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8. MEA
- 8.8.1. South Africa
- 8.8.1.1. Key Country Dynamics
- 8.8.1.2. Regulatory Framework/ Reimbursement Structure
- 8.8.1.3. Competitive Scenario
- 8.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.2. Saudi Arabia
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Framework/ Reimbursement Structure
- 8.8.2.3. Competitive Scenario
- 8.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.3. UAE
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Framework/ Reimbursement Structure
- 8.8.3.3. Competitive Scenario
- 8.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.4. Kuwait
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Framework/ Reimbursement Structure
- 8.8.4.3. Competitive Scenario
- 8.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Key Company Heat Map Analysis, 2024
- 9.4. Company Profiles
- 9.4.1. Zimmer Biomet
- 9.4.1.1. Company Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Stryker
- 9.4.2.1. Company Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Collagen Solutions (US) LLC
- 9.4.3.1. Company Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. BD (Becton, Dickinson and Company)
- 9.4.4.1. Company Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Arthrex, Inc.
- 9.4.5.1. Company Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Anika Therapeutics, Inc.
- 9.4.6.1. Company Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. BE Braun SE
- 9.4.7.1. Company Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Smith+Nephew
- 9.4.8.1. Company Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Vericel Corporation
- 9.4.9.1. Company Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Johnson and Johnson Services, Inc.
- 9.4.10.1. Company Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.11. Medacta International
- 9.4.11.1. Company Overview
- 9.4.11.2. Financial Performance
- 9.4.11.3. Product Benchmarking
- 9.4.11.4. Strategic Initiatives